Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralesional therapies for scars, bruising, and hematomas after submental liposuction and facelift
RBR-9n5rcm9Phase 2Terminated
- Sponsor
- Uningá
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of triamcinolone, fluorouracil, bleomycin, verapamil, hyaluronidase and 2 more in keloid, Hypertrophic Scar (HS), hematoma and 1 more (8 arms), sponsored by Uningá. Started Jan 2025; status: terminated.
02
Drugs
triamcinolonefluorouracilbleomycinverapamilhyaluronidase
03
Conditions
keloidHypertrophic Scar (HS)hematomaecchymosis
Beyond the preview
Go deeper on RBR-9n5rcm9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9n5rcm9.